Vaccine efficacy: Astonishing graph reveals a’significant’ increase in protection.


Vaccine efficacy: Astonishing graph reveals a’significant’ increase in protection.

In comparison to many other European countries, the UK received COVID vaccines quickly, which many health experts now believe contributed to the continent’s high case rates.

But how effective are the vaccines, exactly?

As the winter approaches, health officials across the UK are urging those who are most vulnerable to get their third Covid booster vaccine.

This website examined the most recent data about the Covid vaccines and looked into just how effective these jabs are at protecting people from the virus and its potentially fatal consequences during the week when the booster jabs rollout was extended to all those aged 40 and above.

In those aged 50 and up, the booster vaccine provides “significantly increased protection” against symptomatic Covid, regardless of which vaccine they received previously.

According to a new study conducted by the UK Health Security Agency (UKHSA), two doses of Oxford-AstraZeneca were 44.1 percent effective against symptomatic disease, compared to 62.5 percent for the Pfizer vaccine.

Protection against the disease increased to 93.1 percent two weeks after receiving the booster dose in those who had previously received the AstraZeneca vaccine.

Those who received Pfizer at the start saw their protection increase to 94%.

“We know that protection from the first two vaccines is beginning to wear off in older age groups, leaving millions who need extra protection as we head into winter,” said UKHSA head of immunisation Mary Ramsay.

“That’s why it’s critical that you get your booster as soon as you’re eligible so we can reduce hospitalizations and deaths this winter.”

The study, according to Paul Hunter, a professor of medicine at the University of East Anglia, shows that booster shots are truly effective.

“It confirms what Israel has reported about the booster dose’s impressive effectiveness,” he said.

“This is perhaps even more impressive when you consider that a large percentage of people who haven’t had their booster will have had an infection and thus had some additional protection now.”

“This report also reassures people that whether they started with AstraZeneca or Pfizer, the booster provides similar excellent protection.”

Now, don’t jump to conclusions. It could be anything. Literally anything that’s been recently applied to the oldest cohorts only and has been incredibly effective in preventing cases vs. the unvaccinated. pic.twitter.comTvuaxRfdqB

Yes, there is.

“Brinkwire News in Condensed Form.”


Comments are closed.